GEORGE EDWARD WOODY

Summary

Affiliation: Treatment Research Institute
Country: USA

Publications

  1. ncbi request reprint Overcoming opioid blockade from depot naltrexone (Prodetoxon)
    E M Kruptisky
    St Petersburg Regional Center in Addiction and Psychopharmacology affiliated with Pavlov State Medical University, St Petersburg, Russia
    Addiction 102:1164-5. 2007
  2. pmc Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment
    Anna Pecoraro
    Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Addict Sci Clin Pract 7:20. 2012
  3. pmc Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial
    George E Woody
    Department of Psychiatry, Treatment Research Institute, University of Pennsylvania, 150 S Independence Mall W, Ste 600, Philadelphia, PA 19106, USA
    JAMA 300:2003-11. 2008
  4. ncbi request reprint Substance use among men who have sex with men: comparison with a national household survey
    G E Woody
    University of Pennsylvania Philadelphia Veterans Affairs Medical Center, USA
    J Acquir Immune Defic Syndr 27:86-90. 2001
  5. ncbi request reprint An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride)
    George E Woody
    Treatment Research Institute, School of Medicine, Philadelphia Va University of Pennsylvania, 600 Public Ledger Building, 150 South Independence Mall W, Philadelphia, PA 19106 3475, USA
    Drug Alcohol Depend 72:163-8. 2003
  6. ncbi request reprint HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study
    George E Woody
    University of Pennsylvania, Philadelphia, Pennsylvania 19106 3475, USA
    J Acquir Immune Defic Syndr 33:82-7. 2003
  7. pmc Prescription OxyContin abuse among patients entering addiction treatment
    Deni Carise
    Treatment Systems Section, Treatment Research Institute, 600 Public Ledger Building, 150 South Independence Mall West, Philadelphia, PA 19106 3475, USA
    Am J Psychiatry 164:1750-6. 2007
  8. pmc An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study
    Li Tzy Wu
    Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke Clinical Research Institute, Duke University, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Stud Alcohol Drugs 70:414-25. 2009
  9. pmc Drug treatment as HIV prevention: a research update
    David S Metzger
    HIV AIDS Prevention Research Division, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 55:S32-6. 2010
  10. pmc Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study
    Li Tzy Wu
    Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27710, USA
    J Subst Abuse Treat 38:S70-9. 2010

Detail Information

Publications30

  1. ncbi request reprint Overcoming opioid blockade from depot naltrexone (Prodetoxon)
    E M Kruptisky
    St Petersburg Regional Center in Addiction and Psychopharmacology affiliated with Pavlov State Medical University, St Petersburg, Russia
    Addiction 102:1164-5. 2007
    ..To describe a situation in which an opioid-dependent patient overcame naltrexone blockade. DESIGN, CASE REPORT, SETTING: Addiction treatment center in St Petersburg, Russia...
  2. pmc Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment
    Anna Pecoraro
    Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Addict Sci Clin Pract 7:20. 2012
    ..This program evaluation provides descriptive information on self-reported rates of SUD treatment initiation of all patients and health-care utilization and costs for a subset of patients...
  3. pmc Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial
    George E Woody
    Department of Psychiatry, Treatment Research Institute, University of Pennsylvania, 150 S Independence Mall W, Ste 600, Philadelphia, PA 19106, USA
    JAMA 300:2003-11. 2008
    ..The usual treatment for opioid-addicted youth is detoxification and counseling. Extended medication-assisted therapy may be more helpful...
  4. ncbi request reprint Substance use among men who have sex with men: comparison with a national household survey
    G E Woody
    University of Pennsylvania Philadelphia Veterans Affairs Medical Center, USA
    J Acquir Immune Defic Syndr 27:86-90. 2001
    ..Compare substance use among men who have sex with men (MSM) at high risk for HIV infection to a nationally representative sample of heterosexual men...
  5. ncbi request reprint An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride)
    George E Woody
    Treatment Research Institute, School of Medicine, Philadelphia Va University of Pennsylvania, 600 Public Ledger Building, 150 South Independence Mall W, Philadelphia, PA 19106 3475, USA
    Drug Alcohol Depend 72:163-8. 2003
    ..Assess the validity of medical products reporting program (MEDWatch) reports of abuse/dependence and withdrawal associated with Ultram (tramadol)...
  6. ncbi request reprint HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study
    George E Woody
    University of Pennsylvania, Philadelphia, Pennsylvania 19106 3475, USA
    J Acquir Immune Defic Syndr 33:82-7. 2003
    ..The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients...
  7. pmc Prescription OxyContin abuse among patients entering addiction treatment
    Deni Carise
    Treatment Systems Section, Treatment Research Institute, 600 Public Ledger Building, 150 South Independence Mall West, Philadelphia, PA 19106 3475, USA
    Am J Psychiatry 164:1750-6. 2007
    ..The purpose of this study was to characterize the nature and origins of pharmaceutical opioid addiction among patients presenting at substance abuse treatment programs...
  8. pmc An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study
    Li Tzy Wu
    Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke Clinical Research Institute, Duke University, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Stud Alcohol Drugs 70:414-25. 2009
    ....
  9. pmc Drug treatment as HIV prevention: a research update
    David S Metzger
    HIV AIDS Prevention Research Division, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 55:S32-6. 2010
    ..Although there are challenges to implementing drug treatment programs for maximum impact, the scientific literature leaves no doubt about the effectiveness of drug treatment as an HIV prevention strategy...
  10. pmc Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study
    Li Tzy Wu
    Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27710, USA
    J Subst Abuse Treat 38:S70-9. 2010
    ....
  11. ncbi request reprint Research findings on psychotherapy of addictive disorders
    George E Woody
    Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19106, USA
    Am J Addict 12:S19-26. 2003
    ..Major studies of psychotherapy in the treatment of addictive disorders are reviewed, and background information on psychotherapy and drug counseling is presented...
  12. pmc MET meets the real world: design issues and clinical strategies in the Clinical Trials Network
    Kathleen M Carroll
    Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
    J Subst Abuse Treat 23:73-80. 2002
    ..Issues requiring attention included the diversity in treatments offered across sites, heterogeneity in the study sample, and training of clinicians drawn from the staff of community programs to deliver the study treatments...
  13. ncbi request reprint Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action
    CHARLES P O'BRIEN
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104 6178, USA
    Biol Psychiatry 56:703-13. 2004
  14. pmc Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study
    Kathleen M Carroll
    Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue, West Haven, CT 06516, USA
    Drug Alcohol Depend 81:301-12. 2006
    ....
  15. doi request reprint Penn/VA center for studies of addiction
    CHARLES P O'BRIEN
    University of Pennsylvania, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104 6178, USA
    Neuropharmacology 56:44-7. 2009
    ..Some of the findings that came out of both the Penn/VA laboratory and clinical studies are now widely accepted and form the basis of standard clinical practice. These concepts and evidence will be briefly reviewed below...
  16. pmc Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics
    Samuel A Ball
    Department of Psychiatry, Yale University School of Medicine, APT Foundation, New Haven, CT 06511, USA
    J Consult Clin Psychol 75:556-67. 2007
    ..An independent evaluation of session audiotapes indicated that MET and CAU were highly and comparably discriminable across sites...
  17. pmc Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil
    Flavio Pechansky
    Research Group of Drug Abuse, Department of Psychiatry, Federal University of Rio Grande do Sul, Brazil
    J Urban Health 80:115-26. 2003
    ..Each of these findings has important implications for the design of preventive interventions...
  18. ncbi request reprint Errors in assessing DSM-IV substance use disorders
    Bridget F Grant
    Arch Gen Psychiatry 64:379-80; author reply 381-2. 2007
  19. ncbi request reprint The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS)
    Theodore J Cicero
    Washington University School of Medicine, St Louis, Missouri 63110, USA
    Pain Med 8:157-70. 2007
    ..Thus, its major focus was the detection of abuse of OxyContin and other commonly prescribed opioid analgesics at the three-digit ZIP code level across the country utilizing a number of different detection systems...
  20. ncbi request reprint Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004
    Theodore J Cicero
    Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
    Pharmacoepidemiol Drug Saf 14:851-9. 2005
    ..This provided a unique opportunity to study the potential changes in abuse as the generic and combination products became available...
  21. ncbi request reprint A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain
    Edgar H Adams
    Edgar Adams Consulting, Covance, Princeton, New Jersey 08540, USA
    J Pain Symptom Manage 31:465-76. 2006
    ....
  22. ncbi request reprint The Diversion of Ultram, Ultracet, and generic tramadol HCL
    James A Inciardi
    University of Delaware Research Center, Coral Gables, FL 33134, USA
    J Addict Dis 25:53-8. 2006
    ..Survey data suggest that the diversion of Ultram and other tramadol products is low, and overall, diversion investigators did not consider tramadol to be a problem in their respective jurisdictions...
  23. ncbi request reprint The availability of web sites offering to sell opioid medications without prescriptions
    Robert F Forman
    Medical Affairs Alkermes, Inc, 88 Sidney St, Cambridge, MA 02139, USA
    Am J Psychiatry 163:1233-8. 2006
    ..This study was designed to determine the availability of web sites offering to sell opioid medications without prescriptions...
  24. ncbi request reprint Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur
    Edward C Senay
    Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA
    Drug Alcohol Depend 69:233-41. 2003
    ..These results indicate that physicians and other healthcare professionals need to be aware of the potential of Ultram to induce withdrawal of the classical opioid type, and that atypical withdrawal may also occur...
  25. ncbi request reprint Buprenorphine use: the international experience
    Maria Patrizia Carrieri
    INSERM U379, Marseilles, France
    Clin Infect Dis 43:S197-215. 2006
    ....
  26. ncbi request reprint Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia
    Evgeny M Krupitsky
    St Petersburg Scientific Research Center of Addictions and Psychopharmacology, St Petersburg, Russia
    J Subst Abuse Treat 31:319-28. 2006
    ..More widespread use of naltrexone could be an important addition to addiction treatment and HIV prevention in Russia...
  27. ncbi request reprint Abuse of buprenorphine in the United States: 2003-2005
    Meredith Y Smith
    Risk Management and Health Policy, Purdue Pharma L P, Stamford, CT 06901 3431, USA
    J Addict Dis 26:107-11. 2007
    ..08 (SD +/- 0.09) for Subutex, and 0.16 (SD +/- 0.08) for Suboxone. Findings suggest that these sublingual buprenorphine formulations have a low rate of abuse based on toxico-surveillance data...
  28. ncbi request reprint New horizons: sustained release morphine as agonist treatment
    George E Woody
    Addiction 100:1758-9. 2005
  29. pmc Implications of cannabis use and heavy alcohol use on HIV drug risk behaviors in Russian heroin users
    Alexander Y Walley
    Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center and Boston University School of Medicine, 91 E Concord St, Suite 200, Boston, MA 02118, USA
    AIDS Behav 12:662-9. 2008
    ..1 points). Because of the central role of risky drug behaviors in the Russian HIV epidemic, it is important to understand how the use of multiple substances, including cannabis and alcohol, impacts risky drug behaviors...
  30. ncbi request reprint Naltrexone for heroin dependence treatment in St. Petersburg, Russia
    Evgeny M Krupitsky
    St Petersburg Scientific Research Center of Addictions and Psychopharmacology, affiliated with St Petersburg State Pavlov Medical University, Russia
    J Subst Abuse Treat 26:285-94. 2004
    ..05). Since heroin dependence is the main way HIV is being spread in Russia, naltrexone is likely to improve treatment outcome and help reduce the spread of HIV if it can be made more widely available...

Research Grants17

  1. Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
    GEORGE EDWARD WOODY; Fiscal Year: 2010
    ..The primary outcome will be response to ART as measured by reduction in viral load. ..
  2. Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
    George Woody; Fiscal Year: 2009
    ..The primary outcome will be response to ART as measured by reduction in viral load. ..
  3. Delaware Valley Node of the Clinical Trials Network
    George Woody; Fiscal Year: 2007
    ..abstract_text> ..
  4. Outcome of Treatment for Substance Use Disorders and HIV Risk Reduction
    George Woody; Fiscal Year: 2007
    ..abstract_text> ..
  5. Delaware Valley Node of the Clinical Trials Network
    George Woody; Fiscal Year: 2007
    ..abstract_text> ..
  6. Methadone maintenance and HIV risk in Ukraine
    George Woody; Fiscal Year: 2007
    ....
  7. Addiction Treatment in Russia: Oral and Depot Naltrexone
    George Woody; Fiscal Year: 2007
    ..We hypothesize that outcomes will be better with DIN than ON, and that each will be more effective than placebo. ..
  8. PERSISTENT EFFECTS OF LT/LI DRUG RISK COUNSELING
    George Woody; Fiscal Year: 2002
    ..We also believe this model of intervention has important public health significance as a sustainable, community based, early intervention for drug users. ..
  9. Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
    GEORGE EDWARD WOODY; Fiscal Year: 2010
    ..The primary outcome will be response to ART as measured by reduction in viral load. ..